Migdal Insurance & Financial Holdings Ltd. lifted its position in Camtek Ltd. (NASDAQ:CAMT - Free Report) by 15.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,060,896 shares of the semiconductor company's stock after buying an additional 412,500 shares during the period. Camtek comprises 2.9% of Migdal Insurance & Financial Holdings Ltd.'s portfolio, making the stock its 10th largest holding. Migdal Insurance & Financial Holdings Ltd. owned about 6.56% of Camtek worth $475,204,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC grew its stake in shares of Camtek by 12.3% in the third quarter. Ashton Thomas Private Wealth LLC now owns 1,763 shares of the semiconductor company's stock worth $274,000 after acquiring an additional 193 shares during the period. Associated Banc Corp bought a new position in Camtek during the third quarter valued at approximately $211,000. QRG Capital Management Inc. bought a new position in Camtek during the second quarter valued at approximately $206,000. Whetstone Capital Advisors LLC bought a new position in Camtek during the second quarter valued at approximately $294,000. Finally, Engineers Gate Manager LP boosted its holdings in Camtek by 51.8% in the second quarter. Engineers Gate Manager LP now owns 7,338 shares of the semiconductor company's stock worth $1,197,000 after purchasing an additional 2,505 shares during the last quarter. Institutional investors own 41.93% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on CAMT. Weiss Ratings reissued a "hold (c)" rating on shares of Camtek in a report on Wednesday, November 4th. B. Riley Financial cut their price target on Camtek from $166.00 to $138.00 and set a "buy" rating for the company in a research note on Monday, November 9th. Stifel Nicolaus set a $140.00 price target on shares of Camtek in a research report on Wednesday, November 4th. Morgan Stanley cut shares of Camtek from an "equal weight" rating to an "underweight" rating and lowered their price objective for the stock from $152.00 to $126.00 in a research note on Monday, November 2nd. Finally, Cantor Fitzgerald reissued a "neutral" rating and issued a $175.00 price objective on shares of Camtek in a report on Tuesday, September 22nd. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $164.00.
Get Our Latest Analysis on Camtek
Key Stories Impacting Camtek
Here are a few of the latest stories about CAMT:
- Positive Sentiment: Northland Securities raised its 2027 EPS forecast to $4.72 from $4.60, increasing estimates for several 2027 quarters as well. Northland Securities estimate changes
- Negative Sentiment: Polen International Small Cap Fund reported exiting its Camtek position among its third-quarter portfolio moves. The sale may add to concerns about investor appetite, though it reflects one fund’s decision. Polen fund portfolio moves
- Negative Sentiment: Northland also lowered its Q4 2026 EPS estimate to $1.04 from $1.09 and its FY2026 forecast to $3.25 from $3.35, tempering the more optimistic 2027 revisions. Northland Securities estimate changes
Insider Buying and Selling at Camtek
In other Camtek news, VP Orit Geva-Dvash sold 508 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $175.00, for a total transaction of $88,900.00. Following the sale, the vice president directly owned 5,205 shares of the company's stock, valued at $910,875. The trade was a 8.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 79.40% of the stock is currently owned by company insiders.
Camtek Price Performance
NASDAQ CAMT traded down $3.69 during trading hours on Friday, reaching $101.73. The company's stock had a trading volume of 329,075 shares, compared to its average volume of 575,690. Camtek Ltd. has a 1 year low of $89.13 and a 1 year high of $215.99. The company has a quick ratio of 5.18, a current ratio of 5.85 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 38.53, a PEG ratio of 1.56 and a beta of 1.69. The firm's 50-day moving average price is $133.81 and its 200-day moving average price is $155.04.
Camtek (NASDAQ:CAMT - Get Free Report) last released its earnings results on Wednesday, November 4th. The semiconductor company reported $0.99 EPS for the quarter, hitting the consensus estimate of $0.99. The firm had revenue of $161.29 million for the quarter, compared to the consensus estimate of $160.36 million. Camtek had a net margin of 24.56% and a return on equity of 21.38%. The company's quarterly revenue was up 28.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.82 earnings per share. On average, equities research analysts predict that Camtek Ltd. will post 3.24 EPS for the current fiscal year.
Camtek Company Profile
(
Free Report)
Camtek Ltd. develops, manufactures and sells inspection and metrology equipment used in semiconductor manufacturing. Its systems help manufacturers detect defects and measure features on wafers and other components, supporting quality control as semiconductor devices become smaller and more complex. The company's products serve applications including advanced packaging, memory, image sensors and other semiconductor processes. Camtek combines optical inspection hardware with software to analyze production data and identify issues during manufacturing.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Camtek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Camtek wasn't on the list.
While Camtek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.